EFDID: 102217EFD: View Filing

Issuer: Avalanche Biotechnologies, Inc. (0001501756) - D

Accession: 0001140361-14-034988 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001501756
  • Entity Name:
    Avalanche Biotechnologies, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    1035 O'BRIEN DRIVE, SUITE A
    MENLO PARK, CA 94025
  • Persons:
    Related Persons 8
    Thomas Chalberg
    Executive Officer, Director
    Linda Bain
    Executive Officer
    Mehdi Gasmi
    Executive Officer
    Hans Hull
    Executive Officer
    Mark Blumenkranz
    Director
    Steven Schwartz
    Director
    John McLaughlin
    Director
    Paul Wachter
    Director
EDGAR: Offering Information
  • Accession Date:
    09/08/2014
  • First Sale Date:
    08/05/2014
  • Offering Amount:
    $9,999,995
  • Amount Sold:
    $9,999,995
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Avalanche Biotechnologies, Inc./s/ Linda BainLinda BainChief Financial Officer2014-09-07